| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 63358-49-6 | 阿樸西林; 阿帕西林; 萘啶青霉素; 阿撲西林三水酸; (2S,5R,6R)-6-[(2R)-2-[(2R)-2-氨基-3-(N-甲基氨基甲酰)-丙? | Aspoxicillin; (2S,5R,6R)-6-[(2R)-2-[(2R)-2-Amino-3-(N-methylcarbamoyl)-propionamido]-2-(p-hydroxyphenyl)acetamido]-3,3-dimehtyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid trihydrate |  | C21H27N5O7S.3(H2O) | 詳情 | 供應商 |
| 107097-79-0 | 甲苯磺酸妥舒沙星; 7-(3-氨基吡咯烷-1-基)-1-(2,4-二氟苯基)-6-氟-1,4-二氫-4-氧-1,8-萘啶-3-羧酸對甲苯磺酸 | Tosufloxacin tosilate; 7-(3-Aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid 4-methylbenzenesulfonate hydrate |  | C26H25F3N4O7S | 詳情 | 供應商 |
| 108138-46-1 | 托氟沙星; 7-(3-氨基吡咯烷-1-基)-1-(2,4-二氟苯基)-6-氟-4-氧代-1,8-萘啶-3-羧酸 | Tosufloxacin; 7-(3-Aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid |  | C19H15F3N4O3 | 詳情 | 供應商 |
| 115964-29-9 | 甲苯磺酸妥舒沙星; 甲苯磺酸托氟沙星; 7-(3-氨基吡咯烷-1-基)-1-(2,4-二氟苯基)-6-氟-4-氧代-1,8-萘啶-3-甲酸 | Tosufloxacin tosylate; 7-(3-Aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid 4-methylbenzenesulfonate |  | C26H23F3N4O6S | 詳情 | 供應商 |
| 871307-18-5 | 4-[(3-氯-4-氟苯基)氨基]-6-[(3-吡啶甲基)氨基]-1,7-萘啶-3-甲腈 | 4-[(3-Chloro-4-fluorophenyl)amino]-6-[(3-pyridinylmethyl)amino]-1,7-naphthyridine-3-carbonitrile; 4-(3-chloro-4-fluorophenylamino)-6-(pyridin-3-ylmethylamino)-1,7-naphthyridine-3-carbonitrile; 4-[(3-Chloro-4-fluorophenyl)amino]-6-[(3-pyridinylmethyl)amino]-1,7-naphthyridine-3-carbonitrile |  | C21H14ClFN6 | 詳情 | 供應商 |
| 1931-44-8 | 2-氨基-7-羥基-1,8-萘啶 | 7-AMINO-1,8-NAPHTHYRIDIN-2(8H)-ONE; 7-AMINO-1,8-NAPHTHYRIDIN-2(8H)-ONE; 7-AMINO-1,8-NAPHTHYRIDIN-2-OL; 7-amino-1,8-naphthyridin-2(1H)-one; 2-AMINO-7-HYDROXY-1,8-NAPHTHYRIDINE; 7-Amino-1,2-dihydro-1,8-naphthyridine-2-one |  | C8H7N3O | 詳情 | 供應商 |
| 100490-36-6 | 甲苯磺酸妥舒沙星; 諾托氟沙星; (+)-7-(3-氨基-1-吡咯烷基)-6-氟-1-(2,4-二氟苯基)-1,4-二氫-4-氧代-1,8-萘啶 | TOSUFLOXACIN TOSILATE; 1,8-naphthyridine-3-carboxylicacid,1,4-dihydro-7-(3-amino-1-pyrrolidinyl)-1-(; 4-difluorophenyl)-6-fluoro-4-oxo-; a61827; a67107; abbott61827; 1-(2,4-Difluorophenyl)-6-fluoro-1,4-dihydro-7-(3-aminopyrrolidin-1-yl)-4-oxo-1,8-naphthyridine-3-carboxylic acid; 1,8-Naphthyridine-3-carboxylic acid, 7-(3-amino-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo- (9CI); (+)-7-(3-Amino-1-pyrrolidinyl)-6-fluoro-1-(2，4-difluo-rophenyl)-1，4-dihydrcr-4-oxo-1，8-naphthyridine-3-carboxyli cacid |  | 詳情 | 供應商 | |
| 1032350-13-2 | 8-[4-(1-氨基環(huán)丁基)苯基]-9-苯基-1,2,4-三唑并[3,4-F][1,6]萘啶-3(2H)-酮二鹽酸鹽 | MK-2206 | 無 | C25H23Cl2N5O | 詳情 | 供應商 |
| 624733-88-6 | 1,5-酐-2,3-雙脫氧-3-[[(1R,3S)-3-[[7,8-二氫-3-(三氟甲基)-1,6-萘啶-6(5H)-基]羰基]-3-(1-甲基乙基)環(huán)己基]氨基]-4-O-甲基-D-赤式-戊糖醇; 1,5-酐-2,3-雙脫氧-3-[[(1R,3S)-3-[[7,8-二氫-3-(三氟甲基)-1,6-萘啶-6(5H)-基]羰基]-3-(1-甲基乙基)環(huán)己基]氨基]-4-O-甲基-D-赤式-戊糖醇; 1,5-脫水-2,3-雙脫氧-3-[[(1R,3S)-3-[[7,8-二氫-3-(三氟甲基)-1,6-萘啶-6(5H)-基]羰基]-3-(1-甲基乙基)環(huán)戊基]氨基]-4-O-甲基-D-赤式-戊糖醇 | MK-0812; MK-0812; D-erythro-Pentitol, 1,5-anhydro-2,3-dideoxy-3-[[(1R,3S)-3-[[7,8-dihydro-3-(trifluoromethyl)-1,6-naphthyridin-6(5H)-yl]carbonyl]-3-(1-methylethyl)cyclopentyl]amino]-4-O-methyl-; 1,5-Anhydro-2,3-dideoxy-3-[[(1R,3S)-3-[[7,8-dihydro-3-(trifluoromethyl)-1,6-naphthyridin-6(5H)-yl]carbonyl]-3-(1-methylethyl)cyclopentyl]amino]-4-O-methyl-D-erythro-pentitol; MK0812,MK-0812 |  | C24H34F3N3O3 | 詳情 | 供應商 |